Variables | Total (n = 6140) | NG (n = 1394) | Pre-DM (n = 2884) | DM (n = 1862) | P value |
---|---|---|---|---|---|
Age, years | 58.4 ± 10.4 | 55.9 ± 10.8 | 58.9 ± 10.4 | 59.4 ± 9.8 |  < 0.001 |
Male, % | 4771 (77.7) | 1138(81.6) | 2224(77.1) | 1409(75.7) |  < 0.001 |
BMI, kg/m2 | 25.9 ± 3.2 | 25.7 ± 3.1 | 25.8 ± 3.2 | 26.2 ± 3.2 |  < 0.001 |
Hypertension, % | 3930 (64.0) | 830(59.5) | 1791(62.1) | 1309(70.3) |  < 0.001 |
Dyslipidemia, % | 4241 (69.1) | 906(65.0) | 1910(66.2) | 1425(76.5) |  < 0.001 |
Family history of CAD, % | 1433 (23.3) | 355(25.5) | 653(22.6) | 425(22.8) | 0.101 |
Smoking, % | 3496 (56.9) | 810(58.1) | 1664(57.7) | 1022(54.9) | 0.098 |
Prior MI, % | 1219 (19.9) | 265(19.0) | 567(19.7) | 387(20.8) | 0.426 |
Prior PCI or CABG, % | 1581 (25.7) | 322(23.1) | 729(25.3) | 530(28.5) | 0.002 |
Prior stroke, % | 658 (10.7) | 130(9.3) | 279(9.7) | 249(13.4) |  < 0.001 |
Clinical presentation, % |  < 0.001 | ||||
 SAP | 2572 (41.9) | 537 (38.5) | 1193 (41.4) | 842 (45.2) |  |
 ACS | 3568 (58.1) | 857 (61.5) | 1691 (58.6) | 1020 (54.8) |  |
 LVEF, % | 63.0 ± 7.2 | 63.0 ± 7.2 | 63.3 ± 7.1 | 62.6 ± 7.4 |  < 0.001 |
 FBG, mmol/L | 6.1 ± 2.0 | 4.7 ± 0.4 | 5.2 ± 0.6 | 7.3 ± 2.5 | 0.009 |
 HbA1c, % | 6.6 ± 1.2 | 5.4 ± 0.2 | 6.0 ± 0.2 | 7.5 ± 1.3 |  < 0.001 |
 FIB, mg/dL | 3.40 ± 0.84 | 3.32 ± 0.85 | 3.39 ± 0.85 | 3.47 ± 0.82 |  < 0.001 |
 hs-CRP, mg/L | 3.14 ± 3.77 | 3.06 ± 3.82 | 3.11 ± 3.71 | 3.26 ± 3.82 | 0.260 |
 D-dimer, μg/mL | 0.41 ± 0.65 | 0.38 ± 0.50 | 0.42 ± 0.65 | 0.42 ± 0.73 | 0.376 |
 TC, mmol/L | 4.17 ± 1.09 | 4.18 ± 1.10 | 4.21 ± 1.08 | 4.10 ± 1.10 | 0.004 |
 HDL-C, mmol/L | 1.02 ± 0.28 | 1.01 ± 0.28 | 1.04 ± 0.28 | 0.99 ± 0.27 |  < 0.001 |
 LDL-C, mmol/L | 2.48 ± 0.92 | 2.50 ± 0.94 | 2.51 ± 0.92 | 2.41 ± 0.90 | 0.001 |
 TG, mmol/L | 1.81 ± 1.12 | 1.78 ± 1.09 | 1.75 ± 0.94 | 1.92 ± 1.37 |  < 0.001 |
 Creatinine (μmol/L) | 75.4 ± 16.0 | 75.6 ± 15.9 | 75.5 ± 15.2 | 75.0 ± 17.3 | 0.485 |
 Lesion vessels | 1.4 ± 0.7 | 1.4 ± 0.6 | 1.4 ± 0.7 | 1.5 ± 0.7 |  < 0.001 |
 LM/three-vessel disease, % | 2773 (45.2) | 567 (40.7) | 1224 (42.4) | 982 (52.7) |  < 0.001 |
 SYNTAX scorea | 12.0 ± 8.2 | 11.7 ± 7.9 | 11.7 ± 8.1 | 12.6 ± 8.5 | 0.001 |
 Complete revascularization, % | 3310 (53.9) | 798 (57.2) | 1646 (57.1) | 866 (46.5) |  < 0.001 |
 Number of stents | 1.8 ± 1.2 | 1.8 ± 1.1 | 1.8 ± 1.1 | 1.9 ± 1.3 | 0.028 |
 DES implantation, % | 5778 (94.1) | 1323 (94.9) | 2730 (94.7) | 1725 (92.6) | 0.006 |
Medications at discharge, % | |||||
 Aspirin | 6077 (99.0) | 1372(98.4) | 2859(99.1) | 1846(99.1) | 0.067 |
 Clopidogrel | 6020 (98.0) | 1366(98.0) | 2827(98.0) | 1827(98.1) | 0.959 |
 β-blocker | 5609 (91.4) | 1250(89.7) | 2622(90.9) | 1737(93.3) | 0.001 |
 ACEI/ARB | 3150 (51.3) | 697(50.0) | 1396(48.4) | 1057(56.8) |  < 0.001 |
 CCB | 2875 (46.8) | 604(43.3) | 1341(46.5) | 930(49.9) | 0.001 |
 Statin | 5923 (96.5) | 1332(95.6) | 2801(97.1) | 1790(96.1) | 0.022 |
 Nitrate | 5984 (97.5) | 1358(97.4) | 2820(97.8) | 1806(97.0) | 0.240 |